JSPR•prnewswire•
JSPR Deadline: JSPR Investors Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit
Summary
NEW YORK, Nov. 9, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Jasper Therapeutics, Inc. (NASDAQ: JSPR) between November 30, 2023 and July 3, 2025, both dates inclusive (the "Class Period"), of the important November 18,...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 9, 2025 by prnewswire